Not that it is too important, but the $5 billion is US$5 billion peak sales. Drugs tend to sell at 3x to 5x estimated peak sales at Phase 2. This is between A$23 billion and A$38 billion. Given we have 164m shares on issue this corresponds to a SP of $140 to $231 a share. Oh the Triangle report actually says US$5 to 8 billion for estimated peak sales.
I hope everyone can see why I struggle when I start to talk about the scale of the opportunity Race is chasing - nobody believes this is real.
Not that it is too important, but the $5 billion is US$5 billion...
-
- There are more pages in this discussion • 748 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
